Correlates between basic science and therapeutic interventions: The theory and the practice

Current Opinion in Supportive and Palliative Care

Volumn 8, Issue 3, 2014, Pages 200-207

  Ryan, Richella ^a,b   Spathis, Anna ^b   Booth, Sara ^a,b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breathlessness; Interventions; Mechanisms; Neurophysiology; Targets

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ARTIFICIAL VENTILATION; BEHAVIOR; BRAIN CORTEX; BRAIN STEM; DYSPNEA; EMOTION; HUMAN; METABOLISM; OXYGEN THERAPY; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PROCEDURES; PSYCHOLOGY; SENSORY NERVE; SKELETAL MUSCLE;

AFFERENT PATHWAYS; ANALGESICS, OPIOID; BEHAVIOR; BRAIN STEM; CEREBRAL CORTEX; DYSPNEA; EMOTIONS; HUMANS; MUSCLE, SKELETAL; OXYGEN INHALATION THERAPY; PALLIATIVE CARE; PHYSICAL THERAPY MODALITIES; RESPIRATION, ARTIFICIAL;

EID: 84905739561     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0000000000000070     Document Type: Review

References (43)

1. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185:435-452.
2. Currow DC, Higginson IJ, Johnson MJ. Breathlessness - current and emerging mechanisms, measurement and management: A discussion from an European Association of Palliative Care workshop. Palliat Med 2013; 27:932-938.
3. Booth S, Burkin J, Moffat C, Spathis A. The genesis and assessment of breathlessness. In: Managing breathlessness in clinical practice. 1st ed. London: Springer-Verlag; 2013. pp. 21-23.
4. Bailey PH. The dyspnea-Anxiety-Dyspnea cycle - COPD patients' stories of breathlessness: 'It's scary when you can't breathe'. Qual Health Res 2004; 14:760-778.
5. Mahler DA. Understanding mechanisms and documenting plausibility of palliative interventions for dyspnea. Curr Opin Support Palliat Care 2011; 5:71-76.
6. Burki NK, Lee LY. Mechanisms of dyspnea. Chest 2010; 138:1196-1201.
7. Nishino T. Dyspnoea: Underlying mechanisms and treatment. Br J Anaesth 2011; 106:463-474.
8. Gigliotti F. Mechanisms of dyspnea in healthy subjects. Multidiscip Respir Med 2010; 5:195-201.
9. Banzett RB, Pedersen SH, Schwartzstein RM, Lansing RW. The affective dimension of laboratory dyspnea: Air hunger is more unpleasant than work/ effort. Am J Respir Crit Care Med 2008; 177:1384-1390.
10. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: Review and hypotheses. Respir Physiol Neurobiol 2009; 167:53-60.
11. Von Leupoldt A, Dahme B. Cortical substrates for the perception of dyspnea. Chest 2005; 128:345-354.
12. Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol 2009; 167:72-86.
13. Von Leupoldt A, Dahme B. Differentiation between the sensory and affective dimension of dyspnea during resistive load breathing in normal subjects. Chest 2005; 128:3345-3349.
14. Von Leupoldt A, Seemann N, Gugleva T, Dahme B. Attentional distraction reduces the affective but not the sensory dimension of perceived dyspnea. Respir Med 2007; 101:839-844.
15. Von Leupoldt A, Taube K, Schubert-Heukeshoven S, et al. Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD. Chest 2007; 132:1506-1512.
16. Campbell EJ, Howell JB. The sensation of breathlessness. Br Med bull 1963; 19:36-40.
17. Jolley CJ,Moxham J. A physiological model of patient-Reported breathlessness during daily activities in COPD. Eur Respir Rev 2009; 18:66-79.
18. Abernethy AP, McDonald CF, Frith P, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: A double-Blind, randomised controlled trial. Lancet 2010; 376:784-793.
19. Uronis HE, Currow DC, McCrory DC, et al. Oxygen for relief of dyspnoea in mildly- or nonhypoxaemic patients with cancer: A systematic review and metaanalysis. Br J Cancer 2008; 98:294-299.
20. Eaton T, Lewis C, Young P, et al. Long-Term oxygen therapy improves healthrelated quality of life. Respir Med 2004; 98:285-293.
21. Weil JV, McCullough RE, Kline JS, Sodal IE. Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man. N Engl J Med 1975; 292:1103-1106.
22. Mahler DA. Opioids for refractory dyspnea. Expert Rev Respir Med 2013; 7:123-134.
23. Eckenhoff JE, Oech SR. The effects of narcotics and antagonists upon respiration and circulation in man. A review. Clin Pharmacol Ther 1960; 1:483-524.
24. Meek PM, Adams L, Altose MD, et al. Dyspnea. Mechanisms, assessment, and management: A consensus statement. Am J Respir Crit Care Med 1999; 159:321-340.
25. Sibuya M, Yamada M, Kanamaru A, et al. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease. Am J Respir Crit Care Med 1994; 149:1235-1240.
26. Schwartzstein RM, Lahive K, Pope A, et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987; 136:58-61.
27. Galbraith S, Fagan P, Perkins P, et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010; 39:831-838.
28. Liss HP, Grant BJ. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 137:1285-1288.
29. Bellofiore S, Di Maria GU, Privitera S, et al. Endogenous opioids modulate the increase in ventilatory output and dyspnea during severe acute bronchoconstriction. Am Rev Respir Dis 1990; 142:812-816.
30. Mahler DA, Murray JA, Waterman LA, et al. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J 2009; 33:771-777.
31. Gifford AH, Mahler DA, Waterman LA, et al. Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD. COPD 2011; 8:160-166.
32. Pattinson KTS, Governo RJ, MacIntosh BJ, et al. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci 2009; 29:8177-8186.
33. Banzett RB, Adams L, O'Donnell CR, et al. Using laboratory models to test treatment: Morphine reduces dyspnea and hypercapnic ventilatory response. Am J Respir Crit Care Med 2011; 184:920-927.
34. Von Leupoldt A, Sommer T, Kegat S, et al. Dyspnea and pain share emotionrelated brain network. NeuroImage 2009; 48:200-206.
35. Norweg A, Collins EG. Evidence for cognitive-Behavioral strategies improving dyspnea and related distress in COPD. Int J Chron Obstruct Pulmon Dis 2013; 8:439-451.
36. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; CD003793.
37. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: Joint ACCP/ AACVPR evidence-Based clinical practice guidelines. Chest 2007; 131 (5 Suppl.):4S-42S.
38. Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155:1541-1551.
39. Casaburi R, Patessio A, Ioli F, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143:9-18.
40. Maltais F, LeBlanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155:555-561.
41. Sheel AW, Foster GE, Romer LM. Exercise and its impact on dyspnea. Curr Opin Pharmacol 2011; 11:195-203.
42. Donesky D, Nguyen HQ, Paul SM, Carrieri-Kohlman V. The affective dimension of dyspnea improves in a dyspnea self-management program with exercise training. J Pain Symptom Manage 2014; 47:757-771.
43. Vieira PJC, Güntzel Chiappa AM, Cipriano G, et al. Neuromuscular electrical stimulation improves clinical and physiological function in COPD patients. Respir Med 2014; 108:609-620.